Image
Richard Stanley

DBS Group Holdings announced this morning (Jan 29) that Its CEO, Richard Stanley, had been diagnosed with acute myelogenous leukemia and would be commencing medical treatment in Singapore immediately.

His prognosis came very suddenly; he was busy at work till last Friday.

According to a DBS statement, he sought treatment for what appeared to be ordinary flu-like symptoms on Monday, 26
January, after experiencing a cough and high fever during the Lunar New Year weekend.


Stanley, 48, was warded the following day and his medical condition was confirmed this morning. Previously head of Citigroup China, he was hired by DBS in May last year.


According to Wikipedia, the diseases is a cancer
of the myeloid line of white blood cells, characterized by the rapid proliferation of abnormal cells which accumulate in the bone marrow and interfere with the production of normal blood cells.

AML is the most common acute leukemia affecting adults, and its incidence increases with age.

AML is a relatively rare disease, accounting for approximately 1.2% of cancer deaths in the United States.

ImageKen Watanabe, 49, recovered after chemotherapy treatment

Samurai Ken Watanabe

Among celebrities whom a
cute myelogenous leukemia has afflicted is Ken Watanabe, 49, who is best known outside of Japan for his 2003 film The Last Samurai.

For his performance as Katsumoto, he won an Academy Award nomination for Best Supporting Actor.

Watanabe also appeared in the 2005 films Batman Begins as Ra's Al Ghul and Memoirs of a Geisha, where he played The Chairman.

In 2006, he starred in Clint Eastwood's
film Letters from Iwo Jima

In 2004, he was featured in People's Magazine's 50 Most Beautiful People edition. 

ImageWatanabe in Memoirs of a Geisha
 

His encounter with acute myelogenous leukemia took place years earlier, in 1989, while filming Heaven and Earth

He returned to acting while simultaneously undergoing chemotherapy treatments.

You may also be interested in:


 

We have 981 guests and no members online

rss_2 NextInsight - Latest News